{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:46:48Z","timestamp":1771332408109,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.clon.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T04:06:26Z","timestamp":1587960386000},"page":"e194-e202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma \u2013 Initial Experience From an Australian Liver Cancer Service"],"prefix":"10.1016","volume":"32","author":[{"given":"H.Y.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Leggett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hodgkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fawcett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pryor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2020.04.004_bib1","series-title":"Cancer in Australia 2019. Cancer series no.119. Cat. no. CAN 123","year":"2019"},{"issue":"8","key":"10.1016\/j.clon.2020.04.004_bib3","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5694\/mja18.00373","article-title":"Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study","volume":"209","author":"Hong","year":"2018","journal-title":"Med J Aust"},{"issue":"3","key":"10.1016\/j.clon.2020.04.004_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.13966","article-title":"Hepatocellular carcinoma in Australia 1982\u20132014: increasing incidence and improving survival","volume":"39","author":"Wallace","year":"2019","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.clon.2020.04.004_bib5","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.clon.2020.04.004_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.clon.2020.04.004_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.semradonc.2017.02.002","article-title":"Advances in stereotactic body radiation therapy for hepatocellular carcinoma","volume":"27","author":"Murray","year":"2017","journal-title":"Semin Radiat Oncol"},{"issue":"10127","key":"10.1016\/j.clon.2020.04.004_bib8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.clon.2020.04.004_bib9","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1007\/s10620-007-9750-3","article-title":"Causes of death in patients with unresectable hepatocellular carcinoma","volume":"52","author":"Couto","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.clon.2020.04.004_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2020.04.004_bib11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clon.2020.04.004_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1155\/2015\/824263","article-title":"Hepatocellular carcinoma: consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting","volume":"29","author":"Burak","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.clon.2020.04.004_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818790217","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: current trends and controversies","volume":"17","author":"Schaub","year":"2018","journal-title":"Technol Cancer Res Treat"},{"issue":"X","key":"10.1016\/j.clon.2020.04.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14218\/JCTH.2019.00016","article-title":"Role of radiotherapy in the treatment of hepatocellular carcinoma","volume":"7","author":"Chen","year":"2019","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"4","key":"10.1016\/j.clon.2020.04.004_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000475768","article-title":"Consensus on stereotactic body radiation therapy for small-sized hepatocellular carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting","volume":"6","author":"Zeng","year":"2017","journal-title":"Liver Cancer"},{"key":"10.1016\/j.clon.2020.04.004_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fonc.2019.00345","article-title":"Rethinking the role of radiation therapy in the treatment of unresectable hepatocellular carcinoma: a data driven treatment algorithm for optimizing outcomes","volume":"9","author":"Sayan","year":"2019","journal-title":"Front Oncol"},{"issue":"13","key":"10.1016\/j.clon.2020.04.004_bib17","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.clon.2020.04.004_bib18","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/cncr.27533","article-title":"Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization","volume":"118","author":"Kang","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clon.2020.04.004_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13014-017-0851-7","article-title":"Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma","volume":"12","author":"Gkika","year":"2017","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.clon.2020.04.004_bib20","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.prro.2015.02.007","article-title":"Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1\u20132 trial of stereotactic body radiation therapy","volume":"5","author":"Lasley","year":"2015","journal-title":"Pract Radiat Oncol"},{"issue":"7","key":"10.1016\/j.clon.2020.04.004_bib21","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00432-015-1929-y","article-title":"The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.clon.2020.04.004_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clon.2019.01.012","article-title":"Stereotactic body radiotherapy for small unresectable hepatocellular carcinomas","volume":"31","author":"Yeung","year":"2019","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2020.04.004_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13014-018-1136-5","article-title":"Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis","volume":"13","author":"Shui","year":"2018","journal-title":"Radiat Oncol"},{"issue":"8","key":"10.1016\/j.clon.2020.04.004_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.clon.2019.06.002","article-title":"Contrasting some differences in managing advanced unresectable hepatocellular carcinoma between the East and the West","volume":"31","author":"Lee","year":"2019","journal-title":"Clin Oncol"},{"issue":"14","key":"10.1016\/j.clon.2020.04.004_bib25","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2217\/fon.14.167","article-title":"Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma","volume":"10","author":"Klein","year":"2014","journal-title":"Futur Oncol"},{"issue":"3","key":"10.1016\/j.clon.2020.04.004_bib26","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"10.1016\/j.clon.2020.04.004_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/0284186X.2013.820342","article-title":"Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients","volume":"53","author":"Sanuki","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clon.2020.04.004_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2018.12.005","article-title":"Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"131","author":"Rim","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2020.04.004_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2018.12.013","article-title":"Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma","volume":"131","author":"Kim","year":"2019","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2020.04.004_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1748-717X-9-120","article-title":"The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities","volume":"9","author":"Que","year":"2014","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.clon.2020.04.004_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2014.05.002","article-title":"Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma","volume":"111","author":"Culleton","year":"2014","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.clon.2020.04.004_bib32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaoncol.2015.2189","article-title":"Transcatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma","volume":"1","author":"Huo","year":"2015","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.clon.2020.04.004_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaoncol.2017.5847","article-title":"Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial","volume":"4","author":"Yoon","year":"2018","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.clon.2020.04.004_bib34","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ijrobp.2015.11.048","article-title":"Phase 1 trial of sorafenib and stereotactic body radiation therapy for hepatocellular carcinoma","volume":"94","author":"Brade","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2020.04.004_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520301606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655520301606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:47:49Z","timestamp":1760543269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655520301606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0936655520301606"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2020.04.004","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma \u2013 Initial Experience From an Australian Liver Cancer Service","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights reserved.","name":"copyright","label":"Copyright"}]}}